{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:36:39Z","timestamp":1781940999671,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural scientific research program of Research Project of Chongqing Science and Technology Commission","award":["CSTB2024NSCQ-MSX0486"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0486"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14644-5","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T09:17:33Z","timestamp":1754903853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["SKP2 ubiquitylation modifies IDH1 to regulate hepatoblastoma cell cycle and glucose metabolism"],"prefix":"10.1186","volume":"25","author":[{"given":"Pengxiang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"14644_CR1","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1038\/s41467-022-32473-z","volume":"13","author":"H Song","year":"2022","unstructured":"Song H, Bucher S, Rosenberg K, Tsui M, Burhan D, Hoffman D, Cho S-J, Rangaswami A, Breese M, Leung S, et al. Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids. Nat Commun. 2022;13:4878.","journal-title":"Nat Commun"},{"key":"14644_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.05.031","author":"A Claver\u00eda-Cabello","year":"2023","unstructured":"Claver\u00eda-Cabello A, Herranz JM, Latasa MU, Arechederra M, Uriarte I, Pineda-Lucena A, Prosper F, Berraondo P, Alonso C, Sangro B, et al. Identification and experimental validation of druggable epigenetic targets in hepatoblastoma. J Hepatol. 2023. https:\/\/doi.org\/10.1016\/j.jhep.2023.05.031.","journal-title":"J Hepatol"},{"key":"14644_CR3","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.jhep.2011.10.028","volume":"56","author":"A-L Rougemont","year":"2012","unstructured":"Rougemont A-L, McLin VA, Toso C, Wildhaber BE. Adult hepatoblastoma: learning from children. J Hepatol. 2012;56:1392\u2013403.","journal-title":"J Hepatol"},{"key":"14644_CR4","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.ymthe.2022.01.032","volume":"30","author":"D Wang","year":"2022","unstructured":"Wang D, Tian J, Yan Z, Yuan Q, Wu D, Liu X, Yang S, Guo S, Wang J, Yang Y, et al. Mitochondrial fragmentation is crucial for c-Myc-driven hepatoblastoma-like liver tumors. Mol Therapy: J Am Soc Gene Therapy. 2022;30:1645\u201360.","journal-title":"Mol Therapy: J Am Soc Gene Therapy"},{"key":"14644_CR5","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/HEP.0000000000000534","volume":"79","author":"X Xiang","year":"2024","unstructured":"Xiang X, Hao Y, Cheng C, Hu H, Chen H, Tan J, Wang Y, Liu X, Peng B, Liao J, et al. A TGF-\u03b2-dominant chemoresistant phenotype of hepatoblastoma associated with aflatoxin exposure in children. Hepatology. 2024;79:650\u201365.","journal-title":"Hepatology"},{"key":"14644_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jhep.2022.02.023","volume":"77","author":"R Loesch","year":"2022","unstructured":"Loesch R, Caruso S, Paradis V, Godard C, Gougelet A, Renault G, Picard S, Tanaka I, Renoux-Martin Y, Perret C, et al. Deleting the \u03b2-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth. J Hepatol. 2022;77:424\u201335.","journal-title":"J Hepatol"},{"key":"14644_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2165\/11597740-000000000-00000","volume":"14","author":"R Venkatramani","year":"2012","unstructured":"Venkatramani R, Furman WL, Fuchs J, Warmann SW, Malogolowkin MH. Current and future management strategies for relapsed or progressive hepatoblastoma. Paediatr Drugs. 2012;14:221\u201332.","journal-title":"Paediatr Drugs"},{"key":"14644_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","volume":"18","author":"RL Meyers","year":"2017","unstructured":"Meyers RL, Maibach R, Hiyama E, H\u00e4berle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, et al. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the children\u2019s hepatic tumors international collaboration. Lancet Oncol. 2017;18:122\u201331.","journal-title":"Lancet Oncol"},{"key":"14644_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.semcancer.2020.01.013","volume":"67","author":"Z Cai","year":"2020","unstructured":"Cai Z, Moten A, Peng D, Hsu C-C, Pan B-S, Manne R, Li H-Y, Lin H-K. The Skp2 pathway: A critical target for Cancer therapy. Sem Cancer Biol. 2020;67:16\u201333.","journal-title":"Sem Cancer Biol"},{"key":"14644_CR10","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/med.21675","volume":"40","author":"MD Asmamaw","year":"2020","unstructured":"Asmamaw MD, Liu Y, Zheng Y-C, Shi X-J, Liu H-M. Skp2 in the ubiquitin-proteasome system: a comprehensive review. Med Res Rev. 2020;40:1920\u201349.","journal-title":"Med Res Rev"},{"key":"14644_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41419-022-04685-0","volume":"13","author":"X Yu","year":"2022","unstructured":"Yu X, Zhou L, Liu W, Liu L, Gao F, Li W, Liu H. Skp2 stabilizes Mcl-1 and confers radioresistance in colorectal cancer. Cell Death Dis. 2022;13:249.","journal-title":"Cell Death Dis"},{"key":"14644_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41416-024-02909-y","volume":"132","author":"Y Peng","year":"2025","unstructured":"Peng Y, Qi X, Ding L, Huang J, Liu Y, Zheng R, Fu Y, Yin L, Deng T, Ye Y, et al. SKP2 Inhibition activates tumor cell-intrinsic immunity by inducing DNA replication stress and genomic instability. Br J Cancer. 2025;132:81\u201392.","journal-title":"Br J Cancer"},{"key":"14644_CR13","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.3892\/ol.2020.11818","volume":"20","author":"Z-J Cheng","year":"2020","unstructured":"Cheng Z-J, Cai H-Q, Zhang M-J, Zhong Y, He J, Yuan Q, Hao J-J, Wang M-R, Wan J-H. High S phase kinase-associated protein 2 expression is a potential prognostic biomarker for glioma. Oncol Lett. 2020;20:2788\u201396.","journal-title":"Oncol Lett"},{"key":"14644_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41422-020-0372-z","volume":"31","author":"J Liu","year":"2021","unstructured":"Liu J, Peng Y, Shi L, Wan L, Inuzuka H, Long J, Guo J, Zhang J, Yuan M, Zhang S, et al. Skp2 dictates cell cycle-dependent metabolic Oscillation between Glycolysis and TCA cycle. Cell Res. 2021;31:80\u201393.","journal-title":"Cell Res"},{"key":"14644_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB. The emerging hallmarks of Cancer metabolism. Cell Metabol. 2016;23:27\u201347.","journal-title":"Cell Metabol"},{"key":"14644_CR16","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.2217\/fon-2022-0583","volume":"18","author":"Y Ni","year":"2022","unstructured":"Ni Y, Shen P, Wang X, Liu H, Luo H, Han X. The roles of IDH1 in tumor metabolism and immunity. Future Oncol (London England). 2022;18:3941\u201353.","journal-title":"Future Oncol (London England)"},{"key":"14644_CR17","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1038\/s41388-017-0077-z","volume":"37","author":"RJ Molenaar","year":"2018","unstructured":"Molenaar RJ, Maciejewski JP, Wilmink JW, van Noorden CJF. Wild-type and mutated IDH1\/2 enzymes and therapy responses. Oncogene. 2018;37:1949\u201360.","journal-title":"Oncogene"},{"key":"14644_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1126\/science.1170944","volume":"324","author":"S Zhao","year":"2009","unstructured":"Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P, Yu W, Li Z, Gong L, Peng Y, et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Sci (New York NY). 2009;324:261\u20135.","journal-title":"Sci (New York NY)"},{"key":"14644_CR19","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1111\/cns.14218","volume":"29","author":"W Dong","year":"2023","unstructured":"Dong W, Liu Y, Wang P, Ruan X, Liu L, Xue Y, Ma T, Wang ET, Yang D. U3 snoRNA-mediated degradation of ZBTB7A regulates aerobic glycolysis in isocitrate dehydrogenase 1 wild-type glioblastoma cells. CNS Neurosci Ther. 2023;29:2811\u201325.","journal-title":"CNS Neurosci Ther"},{"key":"14644_CR20","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1089\/ars.2020.8161","volume":"34","author":"M Ushio-Fukai","year":"2021","unstructured":"Ushio-Fukai M, Ash D, Nagarkoti S, Belin de Chantem\u00e8le EJ, Fulton DJR, Fukai T. Interplay between reactive oxygen\/reactive nitrogen species and metabolism in vascular biology and disease. Antioxid Redox Signal. 2021;34:1319\u201354.","journal-title":"Antioxid Redox Signal"},{"key":"14644_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.canlet.2021.05.038","volume":"517","author":"D Ma","year":"2021","unstructured":"Ma D, Zhan D, Fu Y, Wei S, Lal B, Wang J, Li Y, Lopez-Bertoni H, Yalcin F, Dzaye O, et al. Mutant IDH1 promotes phagocytic function of microglia\/macrophages in gliomas by downregulating ICAM1. Cancer Lett. 2021;517:35\u201345.","journal-title":"Cancer Lett"},{"issue":"10","key":"14644_CR22","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/jnci\/djy230","volume":"111","author":"Y Liu","year":"2019","unstructured":"Liu Y, Lu Y, Celiku O, Li A, Wu Q, Zhou Y, Yang C. Targeting IDH1-mutated malignancies with NRF2 blockade. J Natl Cancer Inst. 2019;111(10):1033\u201341.","journal-title":"J Natl Cancer Inst"},{"key":"14644_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06625-6","volume":"15","author":"Z Cui","year":"2024","unstructured":"Cui Z, Li C, Liu W, Sun M, Deng S, Cao J, Yang H, Chen P. Scutellarin activates IDH1 to exert antitumor effects in hepatocellular carcinoma progression. Cell Death Dis. 2024;15: 267.","journal-title":"Cell Death Dis"},{"key":"14644_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1053\/j.semdp.2016.12.015","volume":"34","author":"D Sharma","year":"2017","unstructured":"Sharma D, Subbarao G, Saxena R. Hepatoblastoma. Semin Diagn Pathol. 2017;34:192\u2013200.","journal-title":"Semin Diagn Pathol"},{"key":"14644_CR25","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1002\/cam4.5300","volume":"12","author":"M Honda","year":"2023","unstructured":"Honda M, Uchida K, Irie T, Hirukawa K, Kadohisa M, Shimata K, Isono K, Shimojima N, Sugawara Y, Hibi T. Recent advances in surgical strategies and liver transplantation for hepatoblastoma. Cancer Med. 2023;12:3909\u201318.","journal-title":"Cancer Med"},{"key":"14644_CR26","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s42003-023-05166-6","volume":"6","author":"H Zhou","year":"2023","unstructured":"Zhou H, Zhou L, Guan Q, Hou X, Wang C, Liu L, Wang J, Yu X, Li W, Liu H. Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells. Commun Biology. 2023;6:805.","journal-title":"Commun Biology"},{"key":"14644_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27124-8","volume":"12","author":"S Hume","year":"2021","unstructured":"Hume S, Grou CP, Lascaux P, D\u2019Angiolella V, Legrand AJ, Ramadan K, Dianov GL. The NUCKS1-SKP2-p21\/p27 axis controls S phase entry. Nat Commun. 2021;12: 6959.","journal-title":"Nat Commun"},{"key":"14644_CR28","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41580-022-00462-1","volume":"23","author":"CE Meacham","year":"2022","unstructured":"Meacham CE, DeVilbiss AW, Morrison SJ. Metabolic regulation of somatic stem cells in vivo. Nat Rev Mol Cell Biol. 2022;23:428\u201343.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"14644_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11:325\u201337.","journal-title":"Nat Rev Cancer"},{"key":"14644_CR30","doi-asserted-by":"crossref","unstructured":"Liao M, Yao D, Wu L, Luo C, Wang Z, Zhang J, Liu B. Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer. Acta Pharm Sinica B. 2024;14.","DOI":"10.1016\/j.apsb.2023.12.003"},{"key":"14644_CR31","unstructured":"Yu Q, Xiong X, Sun Y. Targeting Cullin-RING E3 ligases for anti-cancer therapy: efforts on drug discovery. Zhejiang Da Xue Xue Bao Yi Xue Ban = J Zhejiang Univ Med Sci. 2020;49."},{"key":"14644_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13045-020-00885-3","volume":"13","author":"X Li","year":"2020","unstructured":"Li X, Song Y. Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy. J Hematol Oncol. 2020;13:50.","journal-title":"J Hematol Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14644-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14644-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14644-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T20:14:17Z","timestamp":1757362457000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14644-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14644"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14644-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study protocol was approved by the Institutional Ethical Committee of Children\u2019s Hospital Affiliated to Chongqing Medical University. (CHCMU-IACUC20250609003).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1304"}}